Psychedelic Industry News

Market updates, company news, pharmaceutical developments, and industry trends.

Magic Mushrooms Move Mainstream as Science and Policy Lag Behind

Psilocybin is moving into the mainstream faster than science and policy can keep up. Will this interest in move the

Read More

How We Saved One Ketamine Clinic Network $38,000 a Year on Medical Supplies

We just negotiated GPO-level medical supply pricing exclusively for Healing Health Alliance members. The proof: one HHA member ketamine practice

Read More

‘Psychedelics are the next yoga’ — This Billionaire’s Son is Pioneering the Psychedelic Wellness Revolution

The Lululemon founder's son has launched Optimi Health, a pioneering psychedelic company that is betting on the future of mental

Read More

Trump Signs Executive Order to Accelerate FDA Review of Psychedelic Therapies

Trump framed the order as a response to the mental health crisis facing American veterans. Psychedelic therapy advocates are watching

Read More

MindMetrix Wants to Fix the First Step in Mental Health Care: The Diagnosis

A Chicago company is betting that better mental health treatment starts with a better assessment. MindMetrix has built a comprehensive

Read More

Psychedelic Icon Michael Pollan is Worried RFK Jr. Will Actually Be Bad for the Industry

Too kooky or just kooky enough? Michael Pollan is concerned that RFK Jr.'s stances on healthcare will make make psychedelics

Read More

Why the Trump Psychedelics Executive Order Makes This the Most Important Moment to Join the Healing Health Alliance

Something happened in Washington last week that changes the economics of running a ketamine or psychedelic-adjacent clinic in America. President

Read More

What Todd Blanche’s Attorney General Nomination Could Mean for Psychedelics

A recent JD Supra analysis looks at what Todd Blanche’s nomination for attorney general could mean for marijuana and psychedelic

Read More

Psychedelic Therapy Market Surges Toward $10 Billion Future

The psychedelic drugs market is poised for explosive growth, with projections going from $3.63 billion in 2024 to $10.11 billion

Read More

FDA Grants Priority Vouchers to Three Psychedelic Drug Programs

The FDA's decision could deliver the first psychedelic medicine approved by the FDA as soon as this summer.

Read More

Explore Psychedelic Therapy Regions